Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis.

about

Micafungin: an evidence-based review of its place in therapy Pharmacotherapy approaches to antifungal prophylaxis.

P2860

Q27014780-18AFDFE6-BCC3-46BD-A20E-76868FBD8AC2 Q38020238-3E304957-B692-41E6-A988-1A9C3BB915DF

P2860

Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis.

Item

http://www.wikidata.org/entity/Q51177786

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

Medical cost analysis for anti ...... ystematic simulation analysis.

@en

Medical cost analysis for anti ...... ystematic simulation analysis.

@nl

type

Item

label

Medical cost analysis for anti ...... ystematic simulation analysis.

@en

Medical cost analysis for anti ...... ystematic simulation analysis.

@nl

prefLabel

Medical cost analysis for anti ...... ystematic simulation analysis.

@en

Medical cost analysis for anti ...... ystematic simulation analysis.

@nl

P1476

Medical cost analysis for anti ...... ystematic simulation analysis.

@en

P2093

Akira Kitanaka

http://www.w3.org/2001/XMLSchema#string

Hiroaki Ohnishi

http://www.w3.org/2001/XMLSchema#string

Osamu Imataki

http://www.w3.org/2001/XMLSchema#string

Terukazu Tanaka

http://www.w3.org/2001/XMLSchema#string

Toshihiko Ishida

http://www.w3.org/2001/XMLSchema#string

Yoshitsugu Kubota

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia

The cost of treating systemic fungal infections.

Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

Evidence-based assessment of primary antifungal prophylaxis in patients with hematologic malignancies.

Challenges in systematic reviews of economic analyses.

The place for itraconazole in treatment.

P2888

s00520-010-0998-3

P304

1657-1665

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1007/S00520-010-0998-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20830490

http://www.w3.org/2001/XMLSchema#string

Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis.

about

P2860

P2860

Medical cost analysis for antifungal prophylaxis in neutropenic patients with hematological malignancies: a systematic simulation analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698